About: Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 23 August 2010

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2010 (uk) artículu científicu espublizáu n'agostu de 2010 (ast) scientific article published on 23 August 2010 (en) article scientifique publié en août 2010 (fr)
publication date	wds:Q84791586-DD3652AD-9056-403B-A227-EDD67AC977D9
publication date	2010-08-23 00:00:00Z (xsd:dateTime)
author name string	wds:Q84791586-09267BC4-91E4-47FD-826A-32D89ACB23D0 wds:Q84791586-1458314F-2BC7-44F8-A8F8-F450C7A5DAA1 wds:Q84791586-20C17B71-B17D-4086-8FFE-C343B398142B wds:Q84791586-75099D6E-56F6-4DD2-8834-B2B34D0D72AE wds:Q84791586-75D8679A-AE04-4182-B179-CC7A56A790B7 wds:Q84791586-8641F370-7C2A-4D79-9169-73DA5F44E3C1 wds:Q84791586-9AB42780-1EF4-4FBF-A0B0-EAB5DE475C42 wds:Q84791586-D8C451AC-35E4-4F2D-8336-C5E6674D602B wds:Q84791586-E93C4EA5-D7A1-4EE9-98C4-CC6350DAFF03 wds:Q84791586-F1EA57F3-E1F8-472D-831A-3C025503C782
author name string	Scott Patterson Richard H Schwartz Alejandra Gurtman Daniel A Scott Emilio A Emini Stan L Block Sylvia H Yeh Jack Love David C Hurley 004 Study Group
rdfs:label	Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers (en) Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers (nl)
skos:prefLabel	Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers (en) Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers (nl)
name	Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers (en) Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers (nl)
author	wds:Q84791586-405F3C18-F066-4E8E-8D3A-AAC7ED72D6B1 wds:Q84791586-CB9601C6-18B5-48F9-A612-95F8C16D4CCE
author	William C. Gruber Kathrin Jansen
title	wds:Q84791586-7244FA6B-38FF-4706-9340-CEC9C1CE2A32
title	Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers (en)
page(s)	wds:Q84791586-34D2F7B8-ED0A-4DE1-B441-3A1BB1FEE0B7
page(s)	e493-505
instance of	wds:Q84791586-31A7897E-8B4B-417D-B889-F8E8FAB55012
instance of	scholarly article
main subject	wds:Q84791586-89474C1B-9EC5-4167-9BAC-75848D10D9FD wds:Q84791586-9BF00B34-1442-4B51-AEFD-60857D4F9B61
main subject	toddler pneumococcal conjugate vaccine
PubMed ID	wds:Q84791586-4FF8AC19-A8C2-4619-A883-C393AAAD2992
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20732948
PubMed ID	20732948
published in	wds:Q84791586-CAC05FDF-1E55-45F3-BB4B-A577115D340F
published in	Pediatrics
issue	wds:Q84791586-77659F7A-F568-4623-9977-51400C6ED99E
volume	wds:Q84791586-E221E927-EEFD-41A0-98E4-77FDB9F77DDB
issue	3
volume	126
DOI	wds:Q84791586-11CF1220-4851-4798-AC15-961C0E570BA1
DOI	http://dx.doi.org/10.1542/PEDS.2009-3027
DOI	10.1542/PEDS.2009-3027
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q84791586
is cites work of	Dominant role of nucleotide substitution in the diversification of serotype 3 pneumococci over decades and during a single infection The immunogenicity of pneumococcal polysaccharides in infants and children: a meta-regression Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A. Polymicrobial interactions: impact on pathogenesis and human disease Blood cultures in the emergency department evaluation of childhood pneumonia Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial Comparative immunogenicity of 7 and 13-valent pneumococcal conjugate vaccines and the development of functional antibodies to cross-reactive serotypes Surveillance of adverse events following the introduction of 13-valent pneumococcal conjugate vaccine in infants, and comparison with adverse events following 7-valent pneumococcal conjugate vaccine, in Victoria, Australia Pneumococcal vaccine and opsonic pneumococcal antibody. Prediction of pneumococcal conjugate vaccine effectiveness against invasive pneumococcal disease using opsonophagocytic activity and antibody concentrations determined by enzyme-linked immunosorbent assay with 22F adsorption. Protein carriers of conjugate vaccines: characteristics, development, and clinical trials Genomics Reveals the Worldwide Distribution of Multidrug-Resistant Serotype 6E Pneumococci Streptococcus pneumoniae isolates expressing a capsule with epitopes of both serotypes 6A and 6B. Post hoc analysis of a randomized double-blind trial of the correlation of functional and binding antibody responses elicited by 13-valent and 7-valent pneumococcal conjugate vaccines and association with nasopharyngeal colonization Timing of serotype 1 pneumococcal disease suggests the need for evaluation of a booster dose Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada 13-valent pneumococcal conjugate vaccine: a review of its use in infants, children, and adolescents 13-Valent pneumococcal conjugate vaccine (PCV13) in children partially immunized with 7-valent pneumococcal conjugate vaccine (PCV7): a phase 3, open-label trial Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccines in Taiwan A phase 3, randomized, double-blind trial comparing the safety and immunogenicity of the 7-valent and 13-valent pneumococcal conjugate vaccines, given with routine pediatric vaccinations, in healthy infants in Brazil Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine (PCV13) when given as a toddler dose to children immunized with PCV7 as infants Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule. The relationship between pneumococcal serotypes and antibiotic resistance Stability of the pneumococcal population structure in Massachusetts as PCV13 was introduced Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in infants: a meta-analysis Functionality of the pneumococcal antibody response in Down syndrome subjects. Phase 3 trial evaluating the immunogenicity, safety, and tolerability of manufacturing scale 13-valent pneumococcal conjugate vaccine Otitis Media in Fully Vaccinated Preschool Children in the Pneumococcal Conjugate Vaccine Era. A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in N Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children Evaluation of different infant vaccination schedules incorporating pneumococcal vaccination (The Vietnam Pneumococcal Project): protocol of a randomised controlled trial. The 7-valent pneumococcal conjugate vaccine elicits cross-functional opsonophagocytic killing responses to Streptococcus pneumoniae serotype 6D in children TLR7/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birth. Effect of Tdap when administered before, with or after the 13-valent pneumococcal conjugate vaccine (coadministered with the quadrivalent meningococcal conjugate vaccine) in adults: A randomised controlled trial The Modified Surface Killing Assay Distinguishes between Protective and Nonprotective Antibodies to PspA Prevention of Invasive Pneumococcal Disease: Problems Emerged After Some Years of the 13-Valent Pneumococcal Conjugate Vaccine Use. Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naïve adults ≥50 years of age

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software